{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T07:13:22Z","timestamp":1794467602217,"version":"4.9.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T00:00:00Z","timestamp":1647216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T00:00:00Z","timestamp":1647216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG057848"],"award-info":[{"award-number":["AG057848"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RF1AG057570"],"award-info":[{"award-number":["RF1AG057570"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG058913"],"award-info":[{"award-number":["AG058913"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG022374"],"award-info":[{"award-number":["AG022374"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG013616"],"award-info":[{"award-number":["AG013616"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG012101"],"award-info":[{"award-number":["AG012101"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32AG052909"],"award-info":[{"award-number":["T32AG052909"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL111724"],"award-info":[{"award-number":["HL111724"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      In sporadic Alzheimer\u2019s disease (AD), brain amyloid-beta (A\u03b2) deposition is believed to be a consequence of impaired A\u03b2 clearance, but this relationship is not well established in living humans. CSF clearance, a major feature of brain glymphatic clearance (BGC), has been shown to be abnormal in AD murine models. MRI phase contrast and intrathecally delivered contrast studies have reported reduced CSF flow in AD. Using PET and tau tracer\n                      <jats:sup>18<\/jats:sup>\n                      F-THK5117, we previously reported that the ventricular CSF clearance of the PET tracer was reduced in AD and associated with elevated brain A\u03b2 levels.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In the present study, we use two PET tracers,\n                      <jats:sup>18<\/jats:sup>\n                      F-THK5351 and\n                      <jats:sup>11<\/jats:sup>\n                      C-PiB to estimate CSF clearance calculated from early dynamic PET frames in 9 normal controls and 15 AD participants.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      we observed that the ventricular CSF clearance measures were correlated (r\u2009=\u20090.66, p\u2009&lt;\u20090.01), with reductions in AD of 18 and 27%, respectively. We also replicated a significant relationship between ventricular CSF clearance (\n                      <jats:sup>18<\/jats:sup>\n                      F-THK5351) and brain A\u03b2 load (r\u2009=\u2009\u2009\u2212\u20090.64, n\u2009=\u200924, p\u2009&lt;\u20090.01). With a larger sample size, we extended our observations to show that reduced CSF clearance is associated with reductions in cortical thickness and cognitive performance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Overall, the findings support the hypothesis that failed CSF clearance is a feature of AD that is related to A\u03b2 deposition and to the pathology of AD. Longitudinal studies are needed to determine whether failed CSF clearance is a predictor of progressive amyloidosis or its consequence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12987-022-00318-y","type":"journal-article","created":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T08:06:57Z","timestamp":1647245217000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":107,"title":["Decreased CSF clearance and increased brain amyloid in Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3875-3513","authenticated-orcid":false,"given":"Yi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Rusinek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Glodzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Pirraglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Babich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. David","family":"Mozley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadek","family":"Nehmeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silky","family":"Pahlajani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily B.","family":"Tanzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangdong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana O.","family":"Carare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Theise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mony J.","family":"de Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,14]]},"reference":[{"key":"318_CR1","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI10498","volume":"106","author":"M Shibata","year":"2000","unstructured":"Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B, et al. Clearance of Alzheimer\u2019s amyloid-ss(1\u201340) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest. 2000;106:1489\u201399.","journal-title":"J Clin Invest"},{"key":"318_CR2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science. 2002;297:353\u20136.","journal-title":"Science"},{"key":"318_CR3","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","volume":"330","author":"KG Mawuenyega","year":"2010","unstructured":"Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, et al. Decreased clearance of CNS beta-amyloid in Alzheimer\u2019s disease. Science. 2010;330:1774.","journal-title":"Science"},{"key":"318_CR4","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/bpa.12159","volume":"24","author":"CA Hawkes","year":"2014","unstructured":"Hawkes CA, Jayakody N, Johnston DA, Bechmann I, Carare RO. Failure of perivascular drainage of beta-amyloid in cerebral amyloid angiopathy. Brain Pathol. 2014;24:396\u2013403.","journal-title":"Brain Pathol"},{"key":"318_CR5","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14:535\u201362.","journal-title":"Alzheimers Dement"},{"key":"318_CR6","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/nm1438","volume":"12","author":"RJ Bateman","year":"2006","unstructured":"Bateman RJ, Munsell LY, Morris JC, Swarm R, Yarasheski KE, Holtzman DM. Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo. Nat Med. 2006;12:856\u201361.","journal-title":"Nat Med"},{"key":"318_CR7","doi-asserted-by":"crossref","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","volume":"4","author":"JJ Iliff","year":"2012","unstructured":"Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Transl Med. 2012;4:147ra111.","journal-title":"Sci Transl Med"},{"key":"318_CR8","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1126\/science.1240514","volume":"340","author":"M Nedergaard","year":"2013","unstructured":"Nedergaard M. Neuroscience. Garbage truck of the brain. Science. 2013;340:1529\u201330.","journal-title":"Science"},{"key":"318_CR9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature14432","volume":"523","author":"A Louveau","year":"2015","unstructured":"Louveau A, Smirnov I, Keyes TJ, Eccles JD, Rouhani SJ, Peske JD, et al. Structural and functional features of central nervous system lymphatic vessels. Nature. 2015;523:337\u201341.","journal-title":"Nature"},{"key":"318_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03489-0","author":"S Da Mesquita","year":"2021","unstructured":"Da Mesquita S, Papadopoulos Z, Dykstra T, Brase L, Farias FG, Wall M, et al. Meningeal lymphatics affect microglia responses and anti-A\u03b2 immunotherapy. Nature. 2021. https:\/\/doi.org\/10.1038\/s41586-021-03489-0.","journal-title":"Nature"},{"key":"318_CR11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1126\/science.abb8739","volume":"370","author":"M Nedergaard","year":"2020","unstructured":"Nedergaard M, Goldman SA. Glymphatic failure as a final common pathway to dementia. Science (New York, NY). 2020;370:50\u20136.","journal-title":"Science (New York, NY)"},{"key":"318_CR12","doi-asserted-by":"crossref","unstructured":"Benveniste H, Lee H, Ozturk B, Chen X, Koundal S, Vaska P, et al. Glymphatic Cerebrospinal fluid and solute transport quantified by MRI and PET imaging. Neuroscience. 2020. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0306452220307302. Accessed 5 Aug 2021.","DOI":"10.1016\/j.neuroscience.2020.11.014"},{"key":"318_CR13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/jmri.26892","volume":"51","author":"T Taoka","year":"2020","unstructured":"Taoka T, Naganawa S. Glymphatic imaging using MRI. J Magn Reson Imaging. 2020;51:11\u201324.","journal-title":"J Magn Reson Imaging"},{"key":"318_CR14","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.3389\/fphys.2021.769948","volume":"12","author":"NH Mehta","year":"2022","unstructured":"Mehta NH, Sherbansky J, Kamer AR, Carare RO, Butler T, Rusinek H, et al. The brain-nose interface: a potential cerebrospinal fluid clearance site in humans. Front Physiol. 2022;12:2318.","journal-title":"Front Physiol"},{"key":"318_CR15","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121537","volume":"3","author":"G Ringstad","year":"2018","unstructured":"Ringstad G, Valnes LM, Dale AM, Pripp AH, Vatnehol S-AS, Emblem KE, et al. Brain-wide glymphatic enhancement and clearance in humans assessed with MRI. JCI Insight. 2018;3: 121537.","journal-title":"JCI Insight"},{"key":"318_CR16","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.2967\/jnumed.116.187211","volume":"58","author":"MJ de Leon","year":"2017","unstructured":"de Leon MJ, Li Y, Okamura N, Tsui WH, Saint-Louis LA, Glodzik L, et al. Cerebrospinal fluid clearance in Alzheimer Disease measured with dynamic PET. J Nucl Med. 2017;58:1471\u20136.","journal-title":"J Nucl Med"},{"key":"318_CR17","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1007\/978-3-030-00928-1_95","volume-title":"Medical image computing and computer assisted intervention\u2014MICCAI 2018","author":"R Elkin","year":"2018","unstructured":"Elkin R, Nadeem S, Haber E, Steklova K, Lee H, Benveniste H, et al. GlymphVIS: visualizing glymphatic transport pathways using regularized optimal transport. In: Frangi AF, Schnabel JA, Davatzikos C, Alberola-L\u00f3pez C, Fichtinger G, editors., et al., Medical image computing and computer assisted intervention\u2014MICCAI 2018. Cham: Springer International Publishing; 2018. p. 844\u201352."},{"key":"318_CR18","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.2967\/jnumed.118.223834","volume":"60","author":"JJ Schubert","year":"2019","unstructured":"Schubert JJ, Veronese M, Marchitelli L, Bodini B, Tonietto M, Stankoff B, et al. Dynamic 11C-PiB PET shows cerebrospinal fluid flow alterations in alzheimer disease and multiple sclerosis. J Nucl Med. 2019;60:1452\u201360.","journal-title":"J Nucl Med"},{"key":"318_CR19","doi-asserted-by":"crossref","first-page":"e619","DOI":"10.1212\/WNL.0000000000011214","volume":"96","author":"ME Farrell","year":"2021","unstructured":"Farrell ME, Jiang S, Schultz AP, Properzi MJ, Price JC, Becker JA, et al. Defining the lowest threshold for amyloid-PET to predict future cognitive decline and amyloid accumulation. Neurology. 2021;96:e619\u201331.","journal-title":"Neurology"},{"key":"318_CR20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas C, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7:263\u20139.","journal-title":"Alzheimers Dement"},{"key":"318_CR21","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1007\/s00259-016-3453-y","volume":"43","author":"R Harada","year":"2016","unstructured":"Harada R, Furumoto S, Tago T, Katsutoshi F, Ishiki A, Tomita N, et al. Characterization of the radiolabeled metabolite of tau PET tracer 18F-THK5351. Eur J Nucl Med Mol Imaging. 2016;43:2211\u20138.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"318_CR22","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/MNM.0b013e328304e0e1","volume":"29","author":"M Verdurand","year":"2008","unstructured":"Verdurand M, Bort G, Tadino V, Bonnefoi F, Le Bars D, Zimmer L. Automated radiosynthesis of the Pittsburg compound-B using a commercial synthesizer. Nucl Med Commun. 2008;29:920\u20136.","journal-title":"Nucl Med Commun"},{"key":"318_CR23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/cercor\/bhg087","volume":"14","author":"B Fischl","year":"2004","unstructured":"Fischl B, van der Kouwe A, Destrieux C, Halgren E, Segonne F, Salat DH, et al. Automatically parcellating the human cerebral cortex. Cereb Cortex. 2004;14:11\u201322.","journal-title":"Cereb Cortex"},{"key":"318_CR24","doi-asserted-by":"crossref","first-page":"270","DOI":"10.2967\/jnumed.114.149229","volume":"56","author":"Y Li","year":"2015","unstructured":"Li Y, Tsui W, Rusinek H, Butler T, Mosconi L, Pirraglia E, et al. Cortical laminar binding of PET amyloid and tau tracers in Alzheimer disease. J Nucl Med. 2015;56:270\u20133.","journal-title":"J Nucl Med"},{"key":"318_CR25","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.dib.2017.10.024","volume":"15","author":"SL Baker","year":"2017","unstructured":"Baker SL, Maass A, Jagust WJ. Considerations and code for partial volume correcting [18F]-AV-1451 tau PET data. Data Brief. 2017;15:648\u201357.","journal-title":"Data Brief"},{"key":"318_CR26","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00004728-199007000-00011","volume":"14","author":"CC Meltzer","year":"1990","unstructured":"Meltzer CC, Leal JP, Mayberg HS, Wagner HN Jr, Frost JJ. Correction of PET data for partial volume effects in human cerebral cortex by MR imaging. J Comput Assist Tomogr. 1990;14:561\u201370.","journal-title":"J Comput Assist Tomogr"},{"key":"318_CR27","volume":"10","author":"Y Su","year":"2015","unstructured":"Su Y, Blazey TM, Snyder AZ, Raichle ME, Hornbeck RC, Aldea P, et al. Quantitative amyloid imaging using image-derived arterial input function. PLoS ONE. 2015;10: e0122920.","journal-title":"PLoS ONE"},{"key":"318_CR28","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1148\/radiol.2273011499","volume":"227","author":"KH Zou","year":"2003","unstructured":"Zou KH, Tuncali K, Silverman SG. Correlation and simple linear regression. Radiology. 2003;227:617\u201328.","journal-title":"Radiology"},{"key":"318_CR29","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1007\/s00259-008-0833-y","volume":"35","author":"Y Li","year":"2008","unstructured":"Li Y, Rinne JO, Mosconi L, Pirraglia E, Rusinek H, DeSanti S, et al. Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging. 2008;35:2169\u201381.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"318_CR30","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1212\/WNL.40.3_Part_1.500","volume":"40","author":"C May","year":"1990","unstructured":"May C, Kaye JA, Atack JR, Schapiro MB, Friedland RP, Rapoport SI. Cerebrospinal fluid production is reduced in healthy aging. Neurology. 1990;40:500\u20133.","journal-title":"Neurology"},{"key":"318_CR31","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1212\/WNL.57.10.1763","volume":"57","author":"GDH Silverberg","year":"2001","unstructured":"Silverberg GDH. The cerebrospinal fluid production rate is reduced in dementia of the Alzheimer\u2019s type. Neurology. 2001;57:1763\u20136.","journal-title":"Neurology"},{"key":"318_CR32","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","volume":"11","author":"JM Tarasoff-Conway","year":"2015","unstructured":"Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E, et al. Clearance systems in the brain-implications for Alzheimer disease. Nat Rev Neurol. 2015;11:457\u201370.","journal-title":"Nat Rev Neurol"},{"key":"318_CR33","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/ana.24271","volume":"76","author":"BT Kress","year":"2014","unstructured":"Kress BT, Iliff JJ, Xia M, Wang M, Wei HS, Zeppenfeld D, et al. Impairment of paravascular clearance pathways in the aging brain. Ann Neurol. 2014;76:845\u201361.","journal-title":"Ann Neurol"},{"key":"318_CR34","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrn3114","volume":"12","author":"BV Zlokovic","year":"2011","unstructured":"Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders. Nat Rev Neurosci. 2011;12:723\u201338.","journal-title":"Nat Rev Neurosci"},{"key":"318_CR35","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1074\/jbc.M112.438457","volume":"288","author":"K Aston-Mourney","year":"2013","unstructured":"Aston-Mourney K, Zraika S, Udayasankar J, Subramanian SL, Green PS, Kahn SE, et al. Matrix metalloproteinase-9 reduces islet amyloid formation by degrading islet amyloid polypeptide. J Biol Chem. 2013;288:3553\u20139.","journal-title":"J Biol Chem"},{"key":"318_CR36","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1073\/pnas.0230450100","volume":"100","author":"W Farris","year":"2003","unstructured":"Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci USA. 2003;100:4162\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"318_CR37","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1750-3639.2008.00132.x","volume":"18","author":"JS Miners","year":"2008","unstructured":"Miners JS, Baig S, Palmer J, Palmer LE, Kehoe PG, Love S. Abeta-degrading enzymes in Alzheimer\u2019s disease. Brain Pathol. 2008;18:240\u201352.","journal-title":"Brain Pathol"},{"key":"318_CR38","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00401-016-1555-z","volume":"131","author":"AWJ Morris","year":"2016","unstructured":"Morris AWJ, Sharp MM, Albargothy NJ, Fernandes R, Hawkes CA, Verma A, et al. Vascular basement membranes as pathways for the passage of fluid into and out of the brain. Acta Neuropathol. 2016;131:725\u201336.","journal-title":"Acta Neuropathol"},{"key":"318_CR39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1743-8454-7-9","volume":"7","author":"M Pollay","year":"2010","unstructured":"Pollay M. The function and structure of the cerebrospinal fluid outflow system. Cerebrospinal Fluid Res. 2010;7:9.","journal-title":"Cerebrospinal Fluid Res"},{"key":"318_CR40","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0960-894X(01)00734-X","volume":"12","author":"CA Mathis","year":"2002","unstructured":"Mathis CA, Bacskai BJ, Kajdasz ST, McLellan ME, Frosch MP, Hyman BT, et al. A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain. Bioorg Med Chem Lett. 2002;12:295\u20138.","journal-title":"Bioorg Med Chem Lett"},{"key":"318_CR41","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.2967\/jnumed.112.117341","volume":"54","author":"N Okamura","year":"2013","unstructured":"Okamura N, Furumoto S, Harada R, Tago T, Yoshikawa T, Fodero-Tavoletti M, et al. Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease. J Nucl Med. 2013;54:1420\u20137.","journal-title":"J Nucl Med"},{"key":"318_CR42","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2045-8118-8-12","volume":"8","author":"S El Sankari","year":"2011","unstructured":"El Sankari S, Gondry-Jouet C, Fichten A, Godefroy O, Serot JM, Deramond H, et al. Cerebrospinal fluid and blood flow in mild cognitive impairment and Alzheimer\u2019s disease: a differential diagnosis from idiopathic normal pressure hydrocephalus. Fluids Barriers CNS. 2011;8:12.","journal-title":"Fluids Barriers CNS"},{"key":"318_CR43","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fnagi.2019.00087","volume":"11","author":"J Attier-Zmudka","year":"2019","unstructured":"Attier-Zmudka J, S\u00e9rot J-M, Valluy J, Saffarini M, Macaret A-S, Diouf M, et al. Decreased cerebrospinal fluid flow is associated with cognitive deficit in elderly patients. Front Aging Neurosci. 2019;11:87.","journal-title":"Front Aging Neurosci"},{"key":"318_CR44","first-page":"534","volume":"50","author":"PH Luetmer","year":"2002","unstructured":"Luetmer PH, Huston J, Friedman JA, Dixon GR, Petersen RC, Jack CR, et al. Measurement of cerebrospinal fluid flow at the cerebral aqueduct by use of phase-contrast magnetic resonance imaging: technique validation and utility in diagnosing idiopathic normal pressure hydrocephalus. Neurosurgery. 2002;50:534\u201343.","journal-title":"Neurosurgery"},{"key":"318_CR45","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1038\/sj.jcbfm.9600462","volume":"27","author":"S Stoquart-ElSankari","year":"2007","unstructured":"Stoquart-ElSankari S, Bal\u00e9dent O, Gondry-Jouet C, Makki M, Godefroy O, Meyer M-E. Aging effects on cerebral blood and cerebrospinal fluid flows. J Cereb Blood Flow Metab. 2007;27:1563\u201372.","journal-title":"J Cereb Blood Flow Metab"},{"key":"318_CR46","doi-asserted-by":"crossref","first-page":"205846011560963","DOI":"10.1177\/2058460115609635","volume":"4","author":"PK Eide","year":"2015","unstructured":"Eide PK, Ringstad G. MRI with intrathecal MRI gadolinium contrast medium administration: a possible method to assess glymphatic function in human brain. Acta Radiol Open. 2015;4:2058460115609635.","journal-title":"Acta Radiol Open"},{"key":"318_CR47","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1172\/JCI67677","volume":"123","author":"JJ Iliff","year":"2013","unstructured":"Iliff JJ, Lee H, Yu M, Feng T, Logan J, Nedergaard M, et al. Brain-wide pathway for waste clearance captured by contrast-enhanced MRI. J Clin Invest. 2013;123:1299\u2013309.","journal-title":"J Clin Invest"},{"key":"318_CR48","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/2045-8118-11-10","volume":"11","author":"T Brinker","year":"2014","unstructured":"Brinker T, Stopa E, Morrison J, Klinge P. A new look at cerebrospinal fluid circulation. Fluids Barriers CNS. 2014;11:10.","journal-title":"Fluids Barriers CNS"},{"key":"318_CR49","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA. Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science. 1992;256:184\u20135.","journal-title":"Science"},{"key":"318_CR50","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00401-018-1862-7","volume":"136","author":"NJ Albargothy","year":"2018","unstructured":"Albargothy NJ, Johnston DA, MacGregor-Sharp M, Weller RO, Verma A, Hawkes CA, et al. Convective influx\/glymphatic system: tracers injected into the CSF enter and leave the brain along separate periarterial basement membrane pathways. Acta Neuropathol. 2018;136:139\u201352.","journal-title":"Acta Neuropathol"},{"key":"318_CR51","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/sj.jcbfm.9600419","volume":"27","author":"RD Bell","year":"2007","unstructured":"Bell RD, Sagare AP, Friedman AE, Bedi GS, Holtzman DM, Deane R, et al. Transport pathways for clearance of human Alzheimer\u2019s amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system. J Cereb Blood Flow Metab. 2007;27:909\u201318.","journal-title":"J Cereb Blood Flow Metab"},{"key":"318_CR52","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.neuropharm.2014.01.023","volume":"79","author":"H Qosa","year":"2014","unstructured":"Qosa H, Abuasal BS, Romero IA, Weksler B, Couraud P-O, Keller JN, et al. Differences in amyloid-\u03b2 clearance across mouse and human blood-brain barrier models: kinetic analysis and mechanistic modeling. Neuropharmacology. 2014;79:668\u201378.","journal-title":"Neuropharmacology"},{"key":"318_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12987-016-0040-3","author":"SB Hladky","year":"2021","unstructured":"Hladky SB, Barrand MA. Fluid and ion transfer across the blood\u2013brain and blood\u2013cerebrospinal fluid barriers; a comparative account of mechanisms and roles. Fluids Barriers CNS. 2021. https:\/\/doi.org\/10.1186\/s12987-016-0040-3.","journal-title":"Fluids Barriers CNS"},{"key":"318_CR54","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00285-015-0960-6","volume":"73","author":"M Coloma","year":"2016","unstructured":"Coloma M, Schaffer JD, Carare RO, Chiarot PR, Huang P. Pulsations with reflected boundary waves: a hydrodynamic reverse transport mechanism for perivascular drainage in the brain. J Math Biol. 2016;73:469\u201390.","journal-title":"J Math Biol"},{"key":"318_CR55","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2990.2007.00926.x","volume":"34","author":"RO Carare","year":"2008","unstructured":"Carare RO, Bernardes-Silva M, Newman TA, Page AM, Nicoll JA, Perry VH, et al. Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology. Neuropathol Appl Neurobiol. 2008;34:131\u201344.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"318_CR56","first-page":"S21","volume":"9","author":"N Raghavan","year":"2013","unstructured":"Raghavan N, Samtani MN, Farnum M, Yang E, Novak G, Grundman M, et al. The ADAS-Cog revisited: Novel composite scales based on ADAS-Cog to improve efficiency in MCI and early AD trials. Alzheimers Dement. 2013;9:S21-31.","journal-title":"Alzheimers Dement"},{"key":"318_CR57","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/jnnp.2009.204008","volume":"81","author":"SJ Cano","year":"2010","unstructured":"Cano SJ, Posner HB, Moline ML, Hurt SW, Swartz J, Hsu T, et al. The ADAS-cog in Alzheimer\u2019s disease clinical trials: psychometric evaluation of the sum and its parts. J Neurol Neurosurg Psychiatry. 2010;81:1363\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"318_CR58","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1212\/01.wnl.0000228230.26044.a4","volume":"67","author":"MA Mintun","year":"2006","unstructured":"Mintun MA, Larossa GN, Sheline YI, Dence CS, Lee SY, Mach RH, et al. 11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology. 2006;67:446\u201352.","journal-title":"Neurology"},{"key":"318_CR59","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2967\/jnumed.115.164848","volume":"57","author":"R Harada","year":"2016","unstructured":"Harada R, Okamura N, Furumoto S, Furukawa K, Ishiki A, Tomita N, et al. 18F-THK5351: A novel PET radiotracer for imaging neurofibrillary pathology in Alzheimer Disease. J Nucl Med. 2016;57:208\u201314.","journal-title":"J Nucl Med"},{"key":"318_CR60","doi-asserted-by":"crossref","DOI":"10.1016\/j.apradiso.2020.109078","volume":"159","author":"NN Waterhouse","year":"2020","unstructured":"Waterhouse NN, Kothari PJ, Dooley M, Hu B, de Leon MJ, Babich J, et al. Synthesis of [1\u201311C] Butanol via a facile solid phase extraction protocol. Appl Radiat Isot. 2020;159: 109078.","journal-title":"Appl Radiat Isot"},{"key":"318_CR61","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/jcbfm.1992.81","volume":"12","author":"HW Muller-Gartner","year":"1992","unstructured":"Muller-Gartner HW, Links JM, Prince JL, Bryan RN, McVeigh E, Leal JP, et al. Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects. J Cereb Blood Flow Metab. 1992;12:571\u201383.","journal-title":"J Cereb Blood Flow Metab"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-022-00318-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-022-00318-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-022-00318-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T08:08:23Z","timestamp":1647245303000},"score":1,"resource":{"primary":{"URL":"https:\/\/fluidsbarrierscns.biomedcentral.com\/articles\/10.1186\/s12987-022-00318-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,14]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["318"],"URL":"https:\/\/doi.org\/10.1186\/s12987-022-00318-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-900478\/v1","asserted-by":"object"}]},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,14]]},"assertion":[{"value":"13 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"With ethics committee approval, written informed consent was obtained from each participant or their legal caretakers.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The Author hereby consents to publication of the Work in Fluids and Barriers of the CNS. The Author warrants that the Work has not been published before in any form except as a preprint.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}